We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current KRRO market cap is 401.34M. The company's latest EPS is USD -8.6646 and P/E is -4.94.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -12.67M | -41.23M | -21.45M | -24.13M | -23.29M |
| Net Income | -11.61M | -39.22M | -19.56M | -21.83M | -21M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 28.95M | 36.98M | 14.07M | 0 | 0 |
| Operating Income | -20.68M | -27.55M | -84.03M | -83M | -84.53M |
| Net Income | -19.8M | -26.51M | -84.69M | -81.58M | -81.17M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 46.35M | 221.66M | 197.99M | 249.59M | 243.54M |
| Total Liabilities | 9.61M | 51.75M | 46.63M | 51.51M | 63.91M |
| Total Equity | 36.74M | 169.91M | 151.36M | 198.08M | 179.63M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 223.22M | 264.72M | 185.36M | 121.24M | 221.66M |
| Total Liabilities | 55.86M | 72.23M | 54.53M | 52.04M | 51.75M |
| Total Equity | 167.36M | 192.49M | 130.82M | 69.2M | 169.91M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -27.36M | -67.28M | -21.89M | -36.48M | -52.58M |
| Investing | 31.53M | 11.16M | -5.61M | -108M | -120.58M |
| Financing | -14.13M | 187.76M | 139k | 67.7M | 68.42M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 34.22M | -45.19M | -76.06M | -58.24M | -67.28M |
| Investing | -18.26M | 10.4M | -66.13M | 31.13M | 11.16M |
| Financing | 142.02M | 56.69M | 1.36M | -577k | 187.76M |
| Market Cap | 401.34M |
| Price to Earnings Ratio | -4.94 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.41 |
| Price to Book Ratio | 2.36 |
| Dividend Yield | - |
| Shares Outstanding | 9.37M |
| Average Volume (1 week) | 87.95k |
| Average Volume (1 Month) | 121.21k |
| 52 Week Change | -11.16% |
| 52 Week High | 98.00 |
| 52 Week Low | 30.005 |
| Spread (Intraday) | 2.85 (6.65%) |
| Company Name | Korro Bio Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.korrobio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
